{
  "id": 15610562,
  "title": "Sanofi taps new startup ScionxBio for long-acting RNA",
  "url": "https://urgent.news/2026/10/19/sanofi-taps-new-startup-scionxbio-for-long-acting-rna",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-19T13:00:41.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/sanofi-taps-new-startup-scionxbio-for-long-acting-rna/"
  },
  "original_language": "en",
  "account": null,
  "summary": "ScionxBio has inked a deal with French drugmaker Sanofi — its first partnership since splitting from parent company Eleven Therapeutics a few months ago. Under the agreement, ScionxBio will screen Sanofi’s mRNA candidates through its so-called ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}